Source: Pharamceutical Technology

Abu Dhabi Growth Fund: Orbital raises $270m investment for advancement of RNA medicines

Orbital is developing an RNA platform that can combine well-known and upcoming RNA technologies and delivery systems.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Khalifa Al Suwaidi's photo - CEO of Abu Dhabi Growth Fund

CEO

Khalifa Al Suwaidi

CEO Approval Rating

- -/100

Read more